Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Cancer Diagnosis & Prognosis|May 6, 2024
Expression of DNA Repair Genes in Ewing SarcomaAnastasios Kyriazoglou, Myrto Moutafi, Eleni Zografos, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T Taher, M Domenica Cappellini, Yesim Aydinok, et al.
Leukemia & Lymphoma|November 3, 2021
Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphomaGeorgia Avgerinou, Kalliopi Stefanaki, Konstantinos Liapis, et al.
American Journal of Hematology|April 5, 2013
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsAli T Taher, John B Porter, Vip Viprakasit, et al.
Blood|May 3, 2015
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok, Antonis Kattamis, M Domenica Cappellini, et al.
Annals of Hematology|June 19, 2013
Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA studyAli T Taher, John B Porter, Vip Viprakasit, et al.
British Journal of Haematology|October 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trialKhaled M Musallam, Ali T Taher, John B Porter, et al.
Pediatric Hematology and Oncology|June 20, 2019
A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patientsChristianna Vliora, Vassilios Papadakis, Dimitrios Doganis, et al.
Postgraduate Medicine|August 25, 2019
Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experienceEleftheria Kokkinou, Kleoniki Roka, Alexis Alexopoulos, et al.
American Journal of Hematology|November 6, 2018
Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© )Ali Taher, Maria Domenica Cappellini, Vip Viprakasit, et al.
Pageof 17